DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information

Published:2014-02 Issue:2 Volume:5 Page:e1051-e1051
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Amelio I,Gostev M,Knight R A,Willis A E,Melino G,Antonov A V

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis20149.pdf

Reference31 articles.

1. Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 2011; 3: 96ra77.

2. Jin G, Fu C, Zhao H, Cui K, Chang J, Wong ST . A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Res 2012; 72: 33–44.

3. Li YY, Jones SJ . Drug repositioning for personalized medicine. Genome Med 2012; 4: 27.

4. Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, Ferriero R et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA 2010; 107: 14621–14626.

5. Liu Z, Fang H, Reagan K, Xu X, Mendrick DL, Slikker W Jr et al. In silico drug repositioning: what we need to know. Drug Discov Today 2013; 18: 110–115.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARTIFICIAL INTELLIGENCE IN TACKLING CORONAVIRUS AND FUTURE PANDEMICS;Journal of Experimental Biology and Agricultural Sciences;2024-03-15

2. Sulfadiazine Exerts Potential Anticancer Effect in HepG2 and MCF7 Cells by Inhibiting TNFα, IL1b, COX-1, COX-2, 5-LOX Gene Expression: Evidence from In Vitro and Computational Studies;Pharmaceuticals;2024-01-31

3. Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination;Cell Death & Disease;2023-12-18

4. A forgotten dimension of big data in drug repositioning;European Journal of Cancer;2023-10

5. Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition;ACS Pharmacology & Translational Science;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3